Carver Kyle bought EVMN
May 28, 2026 · Form 4 insider transaction
Carver Kyle bought 15,000 shares of Evommune, Inc. at $2.99 per share, a transaction worth $44.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$2.99
Total value
$44.9K
InsiderCarver Kyle
RoleOfficer
CompanyEvommune, Inc. (EVMN)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 28, 2026
Filing dateJune 1, 2026
Shares owned after77,510
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 26, 2026.